Pharmacy Website
Clinic Website

Intelligence » Osteoporosis » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

Could a once-abandoned obesity drug be revived in osteoporosis?

Thursday, December 13, 2018 -- Irisin, the once much-hyped but controversial “exercise hormone” that researchers had hoped would be an effective obesity treatment, could make a comeback—this time in bone strengthening.

Osteoporosis screening guidelines fail to identify fracture risk in younger postmenopausal women

Wednesday, December 12, 2018 -- Current osteoporosis screening and treatment guidelines in the United States and Canada have low sensitivity for identifying younger postmenopausal women who subsequently experience major osteoporotic fracture, according to findings published in the Journal of Bone and Mineral Research.The U.S Preventive Services Task Force screening guide for osteoporosis recommends the use of a formal clinical risk assessment tool for postmenopausal women aged 50 to 64 years to identify candidates for bone mineral density testing, whereas the Canadian strategy recommends BMD testing in women with specific